Global Sickle Cell Disease Treatment Market 2019-2023 | Advent of Regenerative Therapy to Drive Growth | Technavio

LONDON--(BUSINESS WIRE)-- The global sickle cell disease treatment market research report by Technavio predicts the market to post a CAGR of more than 11% during the period 2019-2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190123005457/en/

Technavio has released a new market research report on the global sickle cell disease treatment market for the period 2019-2023. (Graphic: Business Wire)

A key driver for the global sickle cell disease treatment market is the high prevalence of sickle cell disease. The number of cases of sickle cell disease has increased significantly in recent years. However, the market has observed a decrease in the mortality rate during recent years owing to advances in treatment methods such as blood transfusion and bone marrow transplant. The strong prevalence of the disease is expected to attract more vendors as the market growth potential is projected to exceed USD 5 billion over the next five years.

As per Technavio, the advent of regenerative therapy will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global sickle cell disease treatment market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2018-2022.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Global sickle cell disease treatment market: Advent of regenerative therapy

In recent years, the global sickle cell disease treatment market has witnessed significant advances in terms of therapeutics with the advent of regenerative medicines. The research on regenerative therapies such as gene therapy to treat sickle cell diseases is highly promising. Hence, many pharmaceutical vendors are researching these therapies. These advances in research will contribute significantly to the market growth.

“Currently, blood transfusion and hematopoietic stem cells are the only curative option for sickle cell disease and the complicated and painful process of these methods poses a major challenge to adoption. Gene therapy could help in overcoming the painful procedure as it is known to be highly effective to treat various indications. There are ten gene therapy programs that are being studied for sickle cell disease. Therefore, the strong pipeline for sickle cell diseases indicates significant potential for growth over the forecast period,” says a senior research analyst at Technavio.

Global sickle cell disease treatment market: Segmentation analysis

This sickle cell disease treatment market analysis report segments the market by indication (sickle cell anemia, sickle beta thalassemia, and others) and geography (Asia, Europe, North America, and ROW).

The sickle cell anemia segment held the largest sickle cell disease treatment market share in 2018, accounting for more than 58% of the market. This indication segment is expected to dominate the global market throughout the forecast period.

North America led the market in 2018, followed by Europe and Asia, respectively. North America is expected to dominate the market throughout the period 2019-2023.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base comprises enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190123005457/en/